Form 8-K - Current report:
SEC Accession No. 0001140361-25-006745
Filing Date
2025-03-03
Accepted
2025-03-03 16:06:54
Documents
15
Period of Report
2025-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20044777_8k.htm   iXBRL 8-K 29574
2 EXHIBIT 99.1 ef20044777_ex99-1.htm EX-99.1 351738
6 image00005.jpg GRAPHIC 4485
  Complete submission text file 0001140361-25-006745.txt   546279

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adma-20250303.xsd EX-101.SCH 3997
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20250303_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20250303_pre.xml EX-101.PRE 16054
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20044777_8k_htm.xml XML 4030
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 25697826
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)